The American Thyroid Association is pleased to offer content for thyroid professionals looking for education. Programming from the ATA Personalized Approach to Thyroid Disorders and Controversies in Thyroidology cancelled 2020 in-person meetings due to COVID-19 have been transitioned into virtual programs. Learn from leading experts and earn CME and MOC credit all from the comfort of your home or office. Select courses include a live Q&A with faculty. We invite you to join us for our summer series of thyroid education.
Webinars will be released as available over the next few months. Watch on-demand and receive credit for up to one year from the date of webinar release. Registrants will be notified when new content is released.
Virtual Library Credit
Credit is earned on a per webinar basis. Please refer to the presentation for specific credit details. You can see those details here.
No Handout Available
This program does not have any handouts or materials available.
Adina Alazraki, MD, FAAP is an Associate Professor of Radiology and Pediatrics at Emory University School of Medicine and also serves as the Director of Nuclear Medicine at Children’s Healthcare of Atlanta at Egleston. She has been practicing for 12 years with extensive training in body imaging and Nuclear medicine. She completed her undergraduate degree at the University of California, San Diego and received her medical degree from Emory University Medical School. She has been invited to speak and publish on both pediatric body MRI and nuclear medicine including MIBG therapy for neuroblastoma on a national level. She built the body MRI program in pediatrics as well as the PET/CT service and I-131-MIBG therapy programs at Children’s Healthcare of Atlanta, Egleston. She also serves as Co-President of the Southern Pediatric Radiological Society.
Peter Angelos, MD, PhD, FACS is a Linda Kohler Anderson Professor of Surgery and Surgical Ethics, Chief of Endocrine Surgery, and Associate Director of the MacLean Center for Clinical Medical Ethics at the University of Chicago Medicine. He completed his undergraduate degree, medical school, and a Ph.D. in Philosophy at Boston University. He completed his residency in General Surgery at Northwestern University and went on to complete fellowships in Clinical Ethics at the University of Chicago and in Endocrine Surgery at the University of Michigan. Dr. Angelos has written widely on improving outcomes of thyroid and parathyroid surgery, minimally invasive endocrine surgery, and ethical aspects in the care of surgical patients.
Lindsay A Bischoff, MD practices endocrinology at Vanderbilt University Medical Center and is board certified in both Internal Medicine and Endocrinology, Diabetes, & Metabolism. She has a particular interest in the diagnosis and treatment of thyroid nodules, thyroid cancer, and thyroid dysfunction. She is the medical director of the Vanderbilt Thyroid Center, active member of the American Thyroid Association, and is on the thyroid cancer guidelines committee of the National Comprehensive Cancer Network. Dr. Bischoff completed her residency in internal medicine and an endocrine fellowship at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. Before joining the Vanderbilt University Medical Center, she was an active member of the teaching faculty as an Assistant Professor at Sidney Kimmel Medical College at Thomas Jefferson University.
Naifa Busaidy, MD is a Tenured Associate Professor in the Department of Endocrine Neoplasia & Hormonal Disorders at the University of Texas – MD Anderson Cancer Center. Her clinical expertise and research interests are primarily focus driven to treat and improve outcomes in patients with aggressive thyroid carcinomas. Dr Busaidy went to Baylor College of Medicine for medical school and her internal medicine residency. She completed her Endocrine fellowship at the combined program of Baylor College of Medicine and the University of Texas - MD Anderson Cancer Center. Her additional research fellowship year at MD Anderson advanced her clinical and research knowledge in Endocrine Tumors. She joined the faculty at UT MD Anderson Cancer Center in 2004 and climbed the ranks to Tenured Associate Professor. She serves on several institutional committees. There, she also directs the thyroid nodule clinic where they see patients with the spectrum of the disease from initial visit to diagnosis on the same day with results. As an oncologic endocrinologist, she serves as Principal Investigator and Co-Investigator of both National Cancer Institute sponsored and industry sponsored trials and publishes on several clinical trials identifying the molecular mechanisms of disease progression and identify targets for improving response to therapy. She serves on the National Comprehensive Cancer Network (NCCN) Thyroid Cancer Guidelines Committee. She has served as the Endocrine expert on the National Cancer Institute’s PI3K/mTOR taskforce. As well as advisory boards and as a consultant for oncology groups and industry to shape the treatment spectrum of thyroid cancer today. Dr. Busaidy’s service to the American Thyroid Association includes the program committee, research grant committee and the awards committee. She is a member of the International Thyroid Oncology Group Board, AACE, Endocrine Society and several societies where she enjoys serving on multiple committees including mentorship and research committees. She is a fellow of the American Association of Clinical Endocrinologists. She has published extensively on Endocrine tumors, specifically thyroid cancer and Endocrine effects of cancer therapy.
Maria E. Cabanillas, MD is an Oncologic Endocrinologist at the University of Texas MD Anderson Cancer Center in Houston, Texas. She is a tenured Professor and the Faculty Director of Clinical Research in the department of Endocrine Neoplasia at MD Anderson. As a clinician and clinical researcher, she treats both early and advanced thyroid cancers, including medullary, differentiated, and anaplastic thyroid cancers. Her research focus is in advanced and aggressive thyroid cancer, with an emphasis that includes molecular targeted therapies and immunotherapy. Dr. Cabanillas serves as the principal investigator on several clinical trials for the treatment of advanced thyroid cancer and is an IRB vice-chair. She has been a member of the International Thyroid Oncology Group (ITOG) since 2012 and is currently on the Board of Directors.
Anne R. Cappola, MD, ScM is a Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism, Director of Clinical Research in the Department of Medicine, and Director of the Center for Human Phenomic Science at the Perelman School of Medicine at the University of Pennsylvania. Dr. Cappola directs an NIH-funded research program on the hormonal alterations that occur with aging and the clinical impact of these changes, including the clinical impact of subclinical thyroid dysfunction in older individuals. Dr. Cappola is a highly productive investigator who has published over 100 research publications. Dr. Cappola is an elected member of the American Society for Clinical Investigation, the American Association of Physicians, and the Interurban Clinical Club and an Associate Editor for JAMA. She has received the Thyroid Clinical Research Mentor Award from the Endocrine Society and the American Thyroid Association’s Van Meter Award.
Ramona Dadu, MD is an Assistant Professor in the Department of Endocrine Neoplasia and Hormonal Disorders at The University of Texas M.D. Anderson Cancer Center. She completed her research fellowship at Baylor College of Medicine and the UT Texas M.D. Anderson Cancer Center. She is a member of a number of professional societies including the American Thyroid Association, Endocrine Society, American Association of Clinical Endocrinologists and the American Association of Clinical Oncology. Dr. Dadu is a research grant recipient of the ATA.
Douglas Forrest, PhD is a Senior Investigator at the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. He was previously an Associate Professor of Human Genetics at Mount Sinai School of Medicine. He received his PhD from Glasgow University. He has dedicated most of his career to research into the developmental and neurodevelopmental functions of thyroid hormone. His interests include the role of thyroid hormone receptors and deiodination in thyroid hormone action. He is a recipient of the Merck Prize of the European Thyroid Association and the Van Meter Award of the ATA. He is an Associate Editor of Endocrinology. He has served on several committees of the ATA including the committee for Trainee and Career Advancement and is a Board member of the American Thyroid Association.
Whitney Goldner, MD is an Endocrinologist at the University of Nebraska Medical Center, Omaha, NE. She is an Associate Professor of Medicine in the Division of Diabetes, Endocrinology, and Metabolism, Dept of Internal Medicine. She is the PI of ICaRe2, which is a bioinformatics registry and biospecimen bank at UNMC for thyroid nodules and thyroid cancer. She specializes in thyroid disease, thyroid nodules, and thyroid cancer as well as neuroendocrine tumors and other Endocrine disorders. She is the Endocrinology Fellowship Program director and runs the thyroid ultrasound and biopsy clinics.
Patrick Ha, MD, FACS is a Professor and the Chief of Head and Neck Oncologic Surgery in the Department of Otolaryngology – Head and Neck Surgery (OHNS) at the University of California, San Francisco. He also holds the Irwin Mark Jacobs and Joan Klein Jacobs Distinguished Professorship in Head and Neck Surgery. After graduating magna cum laude from Harvard University, he received his medical degree from The Johns Hopkins School of Medicine in Baltimore, Maryland. Dr. Ha completed his one-year internship at The Johns Hopkins Hospital, Baltimore, Maryland, and he also completed an otolaryngology residency from the same institution, followed by advanced training in head and neck surgery at The Johns Hopkins Hospital. In addition to his clinical and research work, he serves as the Medical Director for the UCSF Mission Bay Adult Services.
Steven P. Hodak, MD specializes in thyroid cancer and molecular diagnostics. Dr. Hodak received his medical degree from Georgetown University School of Medicine where he also completed residency training in Internal Medicine, served as Chief Medical Resident and completed fellowship training in Endocrinology and Metabolism. After serving as the Co-Director of the Endocrine Tumor Center at the University of Pittsburgh, he was recruited to NYU Langone Medical Center in 2014. Dr. Hodak is a Professor of Medicine at the NYU School of Medicine and serves as the Associate Director for Clinical Affairs for the Division of Endocrinology, Diabetes and Metabolism; Director of the Faculty Group Practice; and as Section Chief of Endocrinology at NYU Langone Tisch Hospital. Dr. Hodak is board-certified in Endocrinology.
Mimi Hu, MD graduated from Rice University with a degree in mechanical engineering. She obtained her medical degree from the University of Texas - Houston Health Sciences Center. She completed her residency and endocrine fellowship at Baylor College of Medicine, where she also served as chief medical resident. After completion of her research fellowship at MD Anderson, she joined the faculty in 2007 in the department of Endocrine Neoplasia and Hormonal Disorders. Dr. Hu's clinical expertise is in the evaluation and treatment of patients with thyroid carcinoma (differentiated and medullary), hereditary endocrine neoplasia disorders and metabolic bone and mineral disorders. She is the primary investigator and collaborator on multiple clinical trials evaluating various targeted therapies for advanced thyroid carcinoma. She has published articles and book chapters evaluating the management of medullary thyroid carcinoma, multiple endocrine neoplasia, bone health in cancer patients, endocrine complications of head and neck surgery, and paraneoplastic endocrine disorders. She is the director of the Oncologic Endocrine Fellowship program at MD Anderson, the first-of-its-kind training program to provide specialized education in the care and management of patients with endocrine neoplasias/cancers or endocrine complications from cancer or its treatments.
Cari Meinhold Kitahara, PhD, MS is an Investigator in the Division of Cancer Epidemiology and Genetics at the National Cancer Institute, National Institutes of Health. She received an MHS and a PhD in epidemiology from the Johns Hopkins Bloomberg School of Public Health. Dr. Kitahara’s research focuses on the etiology of thyroid cancer and on the potential cancer risks associated with occupational and medical radiation exposure. She is Principal Investigator of the U.S. Radiologic Technologists cohort study and the Hyperthyroid Follow-Up Study (an extension of the original Cooperative Thyrotoxicosis Therapy Follow-up Study assembled in the 1960s). She is the 2019 recipient of the Van Meter Award from the American Thyroid Association and serves on the editorial board of Thyroid. She has authored over 120 peer-reviewed manuscripts.
Tim Korevaar, MD, PhD is a postdoctoral fellow at Erasmus University Medical Center in the Netherlands. After a research internship at the Oxford Center for Diabetes, Endocrinology and Metabolism, Dr. Korevaar obtained his MD at the Erasmus University Medical Center. He obtained a PhD at the Erasmus University Medical Center, Academic Center for Thyroid Diseases focusing on ‘thyroid hormone availability during pregnancy and early life: determinants, interpretation and consequences’ (cum laude). His main interest is to translate thyroid physiological aspects into clinically relevant epidemiological studies. His focus has particularly been on determinants of gestational thyroid function (including hCG and endocrine disrupting chemicals) and the risk of adverse pregnancy and child outcomes (including preterm birth and offspring neurocognition). Dr. Korevaar is the recipient of the British Thyroid Award (2014), ECE Young Investigator Award (2016), the Early Career Clinical Lectureship Award (SfE, 2016) and the Early Career Award of the Royal Dutch Academy of Arts and Sciences (2020). He has authored more than 80 peer-reviewed manuscripts and is coordinator of the Consortium on Thyroid and Pregnancy.
Anupam Kotwal, MD is a board certified Endocrinologist and Assistant Professor at University of Nebraska Medical Center, where he joined after completing endocrinology fellowship at Mayo Clinic. He specializes in thyroid disorders including thyroid nodules, thyroid cancer, and hormone dysfunction with a special interest in cancer immunotherapy-mediated endocrinopathies. His research focuses on identifying immune markers for thyroid cancer prognosis, and characterizing cancer immunotherapy-mediated endocrinopathies. He also provides thyroid related education to the trainees at UNMC.
Masha J. Livhits, MD is an Assistant Professor of Surgery at the UCLA David Geffen School of Medicine. She attended college at the age of 12 through the highly competitive Early Entrance Program at California State University, Los Angeles. After completing her medical education at Washington University in St. Louis, she obtained her surgical training and Endocrine Surgery fellowship at UCLA. Dr. Livhits has published widely in the area of improving surgical outcomes and quality of care. She is dedicated to combining knowledge learned through research with her experience as a surgeon to deliver the best care to her patients. Her clinical and research interests include parathyroid disease, benign and malignant thyroid tumors, adrenal masses, and familial endocrine disorders. She helped to pioneer the new technique of single incision retroperitoneoscopic adrenalectomy in North America.
Sarah C. Oltmann, MD, FACS attended Baylor University, graduating cum laude for her undergraduate degree. She went on to earn her medical degree at Texas Tech University Health Sciences Center, graduating Alpha Omega Alpha. She completed her general surgery residency at the University of Texas Southwestern Medical Center. She pursued endocrine surgery fellowship training at the University of Wisconsin in Madison, WI. After fellowship, she returned to the University of Texas Southwestern and Parkland Health and Hospital Systems, where she now is the Associate Program Chief of Quality and Best Practice for Parkland Health and Hospital Systems, Medical Director of the General Surgery Clinics, and Director of Endocrine Surgery. Her clinical practice focuses on the surgical management of diseases of the thyroid, parathyroid and adrenal glands. Research interests include management and clinical outcomes in endocrine surgery. She is a previous recipient of the ATA/ThyCa Research Grant for her work on cancer progression and therapeutic response in a mouse model of Medullary Thyroid Cancer. She is happily married, with two sons. She is an avid knitter.
Maria Papaleontiou, MD is an Assistant Professor of Internal Medicine at the University of Michigan, Division of Metabolism, Endocrinology and Diabetes. She is a recipient of Fulbright and Howard Hughes Medical Institute scholarships. She is a health services researcher in the field of aging as it pertains to thyroid disorders, including thyroid cancer. She is particularly interested in overtreatment with and misuse of thyroid hormone and their adverse effects in older adults. She is also involved in studies focusing on thyroid cancer outcomes using large cancer registries and surveys. Dr. Papaleontiou is currently funded by a K08 award from the National Institute on Aging. She is active in the American Thyroid Association, the Endocrine Society and the American Association of Clinical Endocrinologists.
Kepal N. Patel, MD is the Chief of the Division of Endocrine Surgery and an Associate Professor of Surgery, Otolaryngology and Biochemistry at NYU Langone Medical Center. He is the Director of the Thyroid Interdisciplinary Program and has particular expertise in the multidisciplinary treatment of Thyroid and Parathyroid disease along with other head and neck tumors. He also leads the translational research program for the Division of Endocrine Surgery. Dr. Patel has been studying the molecular pathogenesis of thyroid carcinoma by focusing on the changes in intracellular pathways that lead to the progression of thyroid cancer. His research interests also include studying the relationship of autoimmune thyroiditis to thyroid cancer at the genomic level.
He earned his M.D. from UMDNJ-Robert Wood Johnson Medical School and completed his Oncologic Head and Neck Surgery training at Memorial Sloan-Kettering Cancer Center. Dr. Patel’s work has been recognized by numerous awards from prestigious societies such as the American Society of Clinical Oncology, American Head and Neck Society, American Association of Endocrine Surgeons, and the American Thyroid Association. He currently serves in multiple leadership roles both locally and nationally and is a reviewer and on the editorial board of several journals.
Elizabeth N. Pearce, MD is currently a Professor of Medicine at Boston University School of Medicine in the Section of Endocrinology, Diabetes, and Nutrition. She received her undergraduate and medical degrees from Harvard and a masters’ degree in epidemiology from the Boston University School of Public Health. She completed her residency in internal medicine at Beth Israel Deaconess Medical Center, and her fellowship in endocrinology at Boston University. Dr. Pearce is the 2018-2019 President of the American Thyroid Association. She also serves as the Regional Coordinator for North America for the Iodine Global Network. She is an Associate Editor at Thyroid and at Endocrine Practice and has served on multiple additional editorial boards, including those for the Journal of Clinical Endocrinology and Metabolism, Clinical Endocrinology, and Lancet Diabetes & Endocrinology. She recently co-chaired the American Thyroid Association’s Thyroid in Pregnancy Guidelines Task Force. Her research interests include the sufficiency of dietary iodine in the U.S., thyroid function in pregnancy, the thyroid effects of environmental perchlorate exposure, and the cardiovascular effects of subclinical thyroid dysfunction. Dr. Pearce was the 2011 recipient of the American Thyroid Association’s Van Meter Award for outstanding contributions to research on the thyroid gland and the 2018 Women in Thyroidology Woman of the Year.
Susan C. Pitt, MD, MPHS, FACS is an Assistant Professor of Surgery in the Division of Endocrine Surgery at the University of Wisconsin School of Medicine and Public Health. Her clinical practice includes patients with benign and malignant thyroid, parathyroid, and adrenal disease. Dr. Pitt’s NIH funded health services research focuses on reducing overtreatment of patients with thyroid cancer. Her research team investigates the role of emotions, like fear and anxiety, on treatment decision-making. They also utilize stakeholder engagement and have developed two decision support tools for patients with low-risk thyroid cancer. In addition to her medical degree from the Medical College of Wisconsin, Dr. Pitt has a master’s degree in Population Health Science from Washington University in St. Louis with a concentration in shared decision-making. She completed her residency at Washington University in St. Louis followed by an Endocrine Surgery fellowship at Brigham and Women’s Hospital. She holds national leadership positions in the Association of Academic Surgery and the Association of Women Surgeons and is an active member of the American Association of Endocrine Surgeons (AAES) and the American Thyroid Association. She is also a past recipient of the AAES Paul LoGerfo Research Award.
Reese W. Randle, MD, FACS is the Assistant Professor of Surgery at Wake Forest Baptist Medical Center. He obtained his medical degree from the University of Texas Health Science Center, Houston. As a board-certified general surgeon with additional fellowship training in endocrine surgery, he specializes in treating benign and malignant disease of the thyroid, parathyroid, and adrenal glands. Dr. Randle’s clinical research interests have largely focused on improving the quality and efficiency of endocrine surgery and improving the safety of surgical training. He has training in both quantitative and qualitative research methods and employ both in the study of thyroid cancer. He serves on the governing committee for the Collaborative Endocrine Surgery Quality Improvement Program through the American Association of Endocrine Surgeons (AAES) and is the alternate representative for the AAES to the Commission on Cancer.
Matthew Ringel, MD is a professor and director of the Division of Endocrinology, Metabolism and Diabetes at The Ohio State University, where he also serves as co-leader of the Cancer Biology Program at the OSUCCC – James and holds the Ralph W. Kurtz Chair in Hormonology. Dr. Ringel focuses his research on molecular mechanisms involved in thyroid cancer invasion and metastasis, with an active interest in new drug testing for thyroid cancer therapy. Among his current research activities is serving as principal investigator (PI) for a National Cancer Institute (NCI) grant-funded study of the “Role of P21-Activated Kinases in Thyroid Cancer.” Dr. Ringel and colleagues have identified a potentially important pathway (p21 activated kinase, or PAK) downstream of the BRAF gene that may be involved in the progression of papillary thyroid cancer, which is incurable when metastatic and progressive. His team hopes to determine the relevance of the PAK pathway in vivo, clarify the mechanism by which it is activated and test novel compounds that block PAK activation with a goal of determining whether PAK is a viable therapeutic target. Dr. Ringel has also served as PI for a multimillion-dollar, NCI-funded program project grant (PPG) to study “Genetic and Signaling Pathways in Epithelial Thyroid Cancer” and for an NCI-funded Specialized Program of Research Excellence (SPORE) grant to help improve the lives of patients with thyroid cancer. Both grants entailed several interactive projects and multiple investigators at Ohio State and other academic institutions.
Jennifer E. Rosen, MD, FACS is Chief of Endocrine Surgery and Vice Chair for Research of the Department of Surgery at Medstar Washington Hospital Center. Dr. Rosen received her undergraduate degree from the University of Pennsylvania and her medical degree from Thomas Jefferson University Medical College. She then completed her residency training in general surgery at Beth Israel Medical Center before completing her fellowship training in surgical oncology at the National Cancer Institute (NCI). Dr. Rosen specializes in the surgical treatment of diseases of the endocrine glands, including the thyroid, parathyroid and adrenal. In addition to surgical techniques, Dr. Rosen works closely with endocrinologists, nuclear medicine physicians and radiologists in order to determine proper testing as well as the best treatment options for each patient. Her clinical interests include treating patients with complex, advanced or recurrent endocrine disease and improving patient outcomes through the use of clinical studies and tailored treatment. Her research interests include bringing in new technology and tools for diagnosing thyroid nodules as well as discriminating cancerous nodules from benign nodules. Dr. Rosen has previously patented tools that are now being used at MedStar Washington Hospital Center. She is currently interested in improving genetic studies in order to predict thyroid cancer in individuals as well as putting together large national databases to look at what improves survival in patients with thyroid cancer. She serves on the Collaborative Endocrine Surgery Quality Improvement Program Committee of the American Association of Endocrine Surgeons (AAES) and sits as a representative of the College to the Commission on Cancer (COC), a program of the American College of Surgeons (ACS). She has been active on numerous committees of the American Thyroid Association (ATA) and serves as Endocrine Section Editor for the Journal of Surgical Oncology.
Mabel M. Ryder, MD is an Endocrinologist and Assistant Professor of Medicine at Mayo Clinic, Rochester. She completed her residency and endocrine fellowship at the University of Cincinnati College of Medicine. Dr. Ryder’s interests are endocrine cancers, thyroid disease and cancer, adrenal disorders and cancer, and the role of tumor microenvironment in facilitating thyroid cancer progressions. She is a member of the American Thyroid Association and International Thyroid Oncology Group.
Jennifer A. Sipos, MD, Program Co-Chair, is a Professor of Medicine and Director of the Benign Thyroid Disorders Program at The Ohio State University. She obtained her medical degree and received her Internal Medicine residency training at Wake Forest University. She completed her Endocrinology and Metabolism fellowship at the University of North Carolina in Chapel Hill. Dr. Sipos has developed an interest in the use of ultrasonography for the diagnosis and management of thyroid cancer and has taught and served as a course director for numerous ultrasound courses nationally and internationally, including meetings for the Endocrine Society, American Thyroid Association, European Thyroid Association, American Association for Clinical Endocrinologists, Asia and Oceania Thyroid Association, Indian Endocrine Society, and International Society of Endocrinology. Additionally, she is actively involved in several clinical research projects with a particular interest in factors implicated in the development of salivary damage after radioiodine therapy. She also participates in clinical trials for the evaluation of multikinase inhibitor therapies in refractory thyroid cancer and the diagnostic use of molecular markers in thyroid nodules.
Rebecca S. Sippel, MD, FACS is Professor of Surgery, Chief of the Division of Endocrine Surgery, and Vice Chair of Academic Affairs and Professional Development at the University of Wisconsin. She is a nationally recognized leader in the field of endocrine surgery. She is currently serving as the program director for the Endocrine Surgery Fellowship at the University of Wisconsin. She is past Secretary of the American Association of Endocrine Surgeons and past President of Association for Academic Surgery. She has a highly productive clinical research program focusing on the diagnosis and management of patients with endocrine disorders and the outcomes of patients after surgery. She is currently PI on an R01 funded randomized controlled trial examining the utility of prophylactic central neck dissection for patients with clinically node negative thyroid cancer.
Leonardo Trasande, MD, MPP is an internationally renowned leader in environmental health. His research focuses on identifying the role of environmental exposures in childhood obesity and cardiovascular risks and documenting the economic costs for policy makers of failing to prevent diseases of environmental origin in children proactively. He also holds appointments in the Wagner School of Public Service and NYU’s College of Global Public Health. He is perhaps best known for a series of studies published in Lancet Diabetes and Endocrinology and the Journal of Clinical Endocrinology and Metabolism that document disease costs due to endocrine disrupting chemicals in the US and Europe of $340 billion and €163 billion annually, respectively. Dr. Trasande leads one of 35 centers across the country as part of the National Institute of Health’s Environmental Influences on Child Health Outcomes program. He is leveraging the NYU Children’s Health and Environment Study as well as another birth cohort to examine phthalates, bisphenols, organophosphate pesticides and polycyclic aromatic hydrocarbons and their effects on fetal as well as postnatal growth and early cardiovascular and renal risks. These two cohorts are part of a larger initiative nationally to identify preventable and environmental factors that influence child health and disease. After receiving his bachelor, medical and public policy degrees from Harvard, he completed the Boston Combined Residency in Pediatrics and a legislative fellowship in the Office of Senator Hillary Rodham Clinton.
Steven G. Waguespack, MD is a Professor in the Department of Endocrine Neoplasia and Hormonal Disorders at the University of Texas MD Anderson Cancer Center in Houston. Board certified in both adult and pediatric endocrinology and recognized as one of "America's Top Doctors for Cancer" in endocrinology, his major clinical and research interests are thyroid cancer, hereditary endocrine tumor syndromes, and pituitary tumors. He is an active member of the American Thyroid Association (ATA), serves on the medical advisory council of ThyCa (Thyroid Cancer Survivors’ Association, Inc.), and has participated in the Thyroid Carcinoma Panel of the NCCN Clinical Practice Guidelines in Oncology. Furthermore, he served as a member of the ATA task force that revised the medullary thyroid cancer guidelines in 2015 and was a co-chair of the inaugural 2015 ATA guidelines for pediatric thyroid nodules and thyroid cancer.
Tracy S. Wang, MD, MPH, FACS is currently Professor of Surgery, Vice-Chair of Strategic and Professional Development, and Chief of the Section of Endocrine Surgery in the Department of Surgery at the Medical College of Wisconsin (Milwaukee, WI). She completed her residency in General Surgery at Long Island Jewish Medical Center and fellowship in Endocrine Surgery at Yale University. Her clinical practice is focused on the surgical endocrine disease of the thyroid, parathyroid, and adrenal glands, including inherited endocrine syndromes. Dr. Wang has published >150 peer-reviewed manuscripts and book chapters. Dr. Wang is the Program Leader for the Endocrine Cancer program at the Froedtert Hospital/Medical College of Wisconsin Cancer Center and Program Director of the MCW Comprehensive Endocrine Surgery Fellowship. She is currently Councilor-at-Large for the Society of Surgical Oncology, President-Elect of the Society of Asian Academic Surgeons, and Treasurer of the American Association of Endocrine Surgeons. She also serves on the Editorial Boards of Clinical Thyroidology, World Journal of Surgery, Journal of Surgical Research, and American Journal of Surgery.
Jonathan D. Wasserman, MD, PhD is an Associate Professor of Pediatrics at the University of Toronto and a Staff Endocrinologist at The Hospital for Sick Children. He completed his PhD in Developmental Biology at the University of Cambridge and his MD at Harvard University & Massachusetts Institute of Technology. He has an active clinical practice with a focus on pediatric endocrine malignancies and in endocrine care of childhood cancer survivors. His research focuses on pediatric thyroid carcinoma using both translational and health services research methodologies. He is an active member of the American Thyroid Association, Canadian Pediatric Endocrine Group and the Pediatric Endocrine Society.
Ari J. Wassner is Medical Director of the Thyroid Center at Boston Children’s Hospital and Assistant Professor of Pediatrics at Harvard Medical School. He earned his MD from Harvard Medical School and completed Pediatric residency followed by fellowship in Pediatric Endocrinology at Boston Children’s Hospital. Dr. Wassner’s clinical specialty is in pediatric thyroid disease with a particular focus on thyroid neoplasia in children and on congenital hypothyroidism, and he is actively engaged in clinical research in these areas. He is a member of the American Thyroid Association and serves on the ATA Pediatric Thyroid Cancer Guidelines Task Force. Dr. Wassner is also Director of the Endocrinology fellowship training program at Boston Children’s Hospital, and he is extensively involved in medical education and curriculum development at Harvard Medical School.
Mark E. Zafereo, Jr., MD is an Associate Professor of Head and Neck Surgery at MD Anderson Cancer Center in Houston, Texas. He is Section Chief of Head and Neck Endocrine Surgery and Associate Medical Director of the Endocrine Center at MD Anderson Cancer Center. Dr. Zafereo holds national committee appointments for the American Head and Neck Society, American Academy of Otolaryngology-Head and Neck Surgery, and American Board of Otolaryngology-Head and Neck Surgery, and he is a Past President of the Houston Society of Otolaryngology-Head and Neck Surgery. He has published extensively on Thyroid and other Head & Neck cancers, speaking nationally and internationally. His clinical practice focuses on patients afflicted with thyroid cancer and parathyroid neoplasms.
Laura Boucai, MD, Program Co-Chair, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Francesco S. Celi, MD, MHSc, Virginia Commonwealth University, Richmond, VA, USA
Ramona Dadu, MD, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Douglas Forrest, PhD, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA
Joanna Klubo-Gwiezdzinska, MD, PhD, MHSc, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA
Peter A. Kopp, MD, Northwestern University, Chicago, IL, USA and University of Lausanne, Lausanne, Switzerland
Maria Papaleontiou, MD, University of Michigan Health System, Ann Arbor, MI, USA
Luca Persani, MD, PhD, University of Milan, Milan, Italy
Wendy Sacks, MD, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Rebecca S. Sippel, MD, University of Wisconsin, Madison, WI, USA
Martha A. Zeiger, MD, FACS, FACE, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Adonia Calhoun Coates, CAE, CMP, American Thyroid Association, Falls Church, VA
American Thyroid Association® Board of Directors
Whitney S. Goldner, MD, Program Co-Chair, University of Nebraska Medical Center, Omaha, NE, USA
Kepal Patel, MD, Program Co-Chair, New York University School of Medicine, New York, NY, USA
Gregory A. Brent, MD, VA Greater Los Angeles Healthcare System – University of California, Los Angeles, CA, USA
James D. Brierley, MB, Princess Margaret Hospital, Toronto, Ontario, Canada
Louise Davies, MD, MS, FACS, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA
Stephanie A. Fish, MD, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Loren Wissner Greene, MD, MA, New York University School of Medicine, New York, NY, USA
George J. Kahaly, MD, PhD, Johannes Gutenberg University Medical Center, Mainz, Germany
Angela M. Leung, MD, MSc, University of California, Los Angeles, CA and VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA
Michael T. McDermott, MD, Program CME Course Director, University of Colorado Hospital, Aurora, Colorado
Mary H. Samuels, MD, Oregon Health & Sciences University, Portland, OR, USA
Jonathan D. Wasserman, MD, PhD, Hospital for Sick Children, Toronto, Ontario, Canada
Martha A. Zeiger, MD, FACS, FACE, Board Liaison, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Adonia Calhoun Coates, CAE, CMP, Staff Liaison, American Thyroid Association, Falls Church, VA, USA
Josette Paige, CMP, CMM, Staff Liaison, American Thyroid Association, Falls Church, VA, USA
|Event Date||Program Title:||Course Details|
|05/29/2020 @ 01:00 PM (EDT)||
Controversies in Thyroidology: Clinical Application of Molecular Testing in the Treatment of Advanced and Metastatic
||More info »|
|06/03/2020 @ 02:00 PM (EDT)||
Personalized Approach to Thyroid Disorders Part 1: Case Presentations
||More info »|
|06/24/2020 @ 02:00 PM (EDT)||
Personalized Approach to Thyroid Disorders Part 2: Lectures
||More info »|
|07/08/2020 @ 01:00 PM (EDT)||
Controversies in Thyroidology: The Urgent Threat of Thyroid and Other Hormone-Disrupting Chemicals to Our Health and Future...and What We Can Do About It
||More info »|
|07/14/2020 @ 02:00 PM (EDT)||
Controversies in Thyroidology: Ablative Technologies for Benign and Malignant Thyroid Disease
||More info »|
|07/22/2020 @ 01:00 PM (EDT)||
Controversies in Thyroidology: Sonographic Evaluation of Thyroid Nodules: TIRADs vs ATA Scoring System
||More info »|
|07/31/2020 @ 12:00 PM (EDT)||
Controversies in Thyroidology: Advanced Pediatric Thyroid Cancer – Treatment Controversies
||More info »|
|08/05/2020 @ 01:00 PM (EDT)||
Controversies in Thyroidology: Immunotherapy and Thyroid Dysfunction
||More info »|
|08/10/2020 @ 01:00 PM (EDT)||
Controversies in Thyroidology: Controversies Regarding the Role of Molecular Testing in Thyroid Nodules: A Case Based Discussion
||More info »|
|08/19/2020 @ 01:00 PM (EDT)||
Controversies in Thyroidology: What’s on the Horizon in Clinical Thyroidology?
||More info »|
|Total Webinar CE Credits Information|
Please wait ...